13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

News

The conference programme of BioFIT 2024 is out !

Discover the conference programme of BioFIT 2024

Share your knowledge at BioFIT 2024

Steered by a distinguished Committee, the BioFIT conference programme brings together bright minds to discuss the latest trends in Life Sciences, to debate innovative topics, to encourage learning and generate conversations that matter.

More than 60 international experts will address current industry issues such as: the right funding sources for early-stage innovation, best practices in academia-industry R&D collaborations, winning ways to nurture early-stage assets and animal health highlights.

Find out more about the BioFIT 2024 conference topics below

Spotlight session

Tuesday, December 3rd, 2024 | 11.15 am – 12.30 pm
Pharma M&As are back, what does it mean for early-stage dealmaking?

While deal volumes have slowed in recent years, in line with overall M&A activity, deals in the life sciences sector appeared to be picking up slightly at the end of 2023. In 2024, lower valuations are expected to provide pharmaceutical companies with additional transaction and acquisition opportunities at a later stage to strengthen portfolios in the face of impending patent expiry, and at an earlier stage as part of a highly selective strategy.
Panellists will look into this seeming resurgence of M&A and its implications for early-stage deals, discussing funding availability, business development prospects and deal pattern observations.

TRACK 1: Best practices in academia-industry R&D collaborations

TRACK 2: Nurturing and licensing early-stage assets

Early-stage assets evolve in an ecosystem where TTOs, scientists and entrepreneurs are closely connected. Understanding the mechanisms and difficulties of nurturing and licensing assets is key to properly influence the valuation of assets at an early stage. How can we fully understand the proposition behind the value? How can we transform science into business more frequently and efficiently?

TRACK 3: From pre-seed to Series A: Accessing early-stage investment

This track aims to understand the mechanisms enforcing investors’ presence in early stages of development. Are we witnessing surges of investment in specific therapeutic areas? Who are the new players involved in investing on the biotech sector and what are their pre-requisites? Are there increasing interactions and partnerships between pharma and VCs at these initial stages?

TRACK 4: Animal health highlights

This track features the latest innovation challenges in animal health R&D and intends to provide a clear understanding of the bridges that can be built between human and animal health. International experts from veterinary research and industry will discuss the latest initiatives to improve and accelerate the development of new diagnostics, vaccines and pharmaceuticals for animal diseases and beyond.

Topic to be announced soon!

Project - CEO Matchmaking

Wednesday, December 4th | 2.00 – 3.00 pm
The path to becoming a successful CEO: Tips to wanabee founders

The Project – CEO matchmaking activity aims to connect representatives of emerging start-ups, technology transfer offices, incubators and investing networks with CEOs and aspiring CEOs. It includes a dedicated visibility for projects looking for CEOs on the partnering platform and a dedicated conference around recruitment or team-building issues.

conference biofit 2023
conference biofit 2023
conference biofit 2023

The conference programme of BioFIT 2024 is out ! Read More »

pitch biofit 2023

Boost your innovation : BioFIT 2024 pitch sessions await !

Boost your innovation on BioFIT 2024

Are you ready to present your groundbreaking projects and technologies to an audience of Life Sciences and Animal Health experts, investors, and potential collaborators? Then, the BioFIT pitch sessions are for you!

Scheduled for December 3rd and 4th, 2024, in Lille, BioFIT is Europe’s leading partnering event for early-stage deals and investment rounds, bringing together 1,000 innovators, investors and industry leaders from the Life Sciences sector.

Why should you pitch at BioFIT ?

Increase your visibility

Position your project in front of a diverse and influential audience

Expand your network

Identify and connect with potential partners who can drive your development

Get valuable feedback

Receive valuable insights from Life Sciences experts to refine and improve your initiatives

Unlock exciting oppotunities

Access potential funding, partnerships and collaborations that could shape the future innovation

How does it work ?

1.Apply in the pitch sessions category that best suits your project : 

pitch biofit 2023

Start-up Slams

If you are a young promising company seeking to raise a seed or Series A financing round

Collaborative and Licensing Opportunity Presentations

If you are a TTO, university, research institute or company with an early-stage technology looking to initiate a collaboration project and/or a licensing deal

Animal Health Presentations

If you have any therapeutic innovations or diagnostic solution for animal health. The Animal Health Presentations are co-organised by SIMV

2.Be selected by a jury composed of high-level representatives and international experts from public and private institutions, life sciences industries and investors

3.Pitch and be awarded : the winners will be recognised as the most innovative project or technology in the sector

  • The only condition to apply to this competitions to be registered as a delegate or an exhibitor
  • The deadline to apply to the pitch sessions is September 26th, 2024

Hear from our 2023 Collaborative and Licensing Opportunity Presentations winner !

Boost your innovation : BioFIT 2024 pitch sessions await ! Read More »

BioFIT 2024, THE business convention in healthcare industry

BioFIT 2024, THE business convention in healthcare industry

Amplify your impact at BioFIT: Secure your exhibition stand now!

BioFIT, leading European partnering event for early-stage deals and investment rounds, brings together 1,000 innovators, investors and industry leaders from the Life Sciences sector. 
Attendees enjoy a multi-faceted experience, including one-on-one meetings, insightful conferences, a vibrant exhibition showcasing cutting-edge solutions, and engaging pitch sessions. The event provides a unique platform for collaboration and knowledge sharing. 

Taking place in Lille on December 3rd and 4th and on December 11th and 12th for online meetings, BioFIT 2024 promises to be an inspiring gathering where breakthrough ideas and strategic alliances will be forged to drive the healthcare industry into the future.

Why secure your stand today ?

Gain unique visibility

Present your company, products, and expertise to a highly targeted audience in a dedicated space. This allows you to attract the attention of potential customers, partners, and stakeholders.

Live demonstration

Exhibitors can provide live demonstrations of their products or services, allowing potential customers to see them in action.

Direct interaction

Exhibitors have the opportunity to engage directly with attendees, including potential customers, partners and industry influencers.

Better fee, better placement

The "Super Early Bird" offer runs until March 28th. Stand space will be allocated on a "first come, first served" basis, so be quick!

Still hesitating ? Find out what our 2023 exhibitors thought of the event !

In 2024, BioFIT will be organised together with MedFIT, dedicated to innovation partnerships and investment rounds in the MedTech and Diagnostic sectors, as well as MEDigIT, the new European convention for Digital Health innovation.

To make sure you don’t miss out on any BioFIT 2024 news, sign up for our >> newsletter <<

Sponsors

Contact

Vincent Tavernier

BioFIT 2024, THE business convention in healthcare industry Read More »

The BioFIT event team wishes you a Happy New Year 2024

The BioFIT event team wishes you a Happy New Year 2024

As we step into the promising horizon of 2024, the entire BioFIT team wishes you a year of health, success and groundbreaking discoveries.

2023 was an incredible journey, and we are grateful to every member of the BioFIT community for your unwavering support, enthusiasm, and dedication to Life Sciences innovation. Together, we are improving the early-stage biotech and pharma landscapes, making meaningful connections and leading the way to a future of progress.

What awaits in 2024, for the 13th edition of BioFIT:

1. Dynamic collaborations:  Prepare for a variety of tailored one-on-one meetings that foster connections and strategic alliances to drive innovation forward.

2. Insightful conferences: Engage in informative conferences that reveal the latest trends and advancements, empowering you with knowledge and foresight.

3. Vibrant exhibition: Experience a dynamic exhibition space featuring state-of-the-art solutions and encouraging collaboration between innovators and industry leaders.

4. Engaging pitch sessions: Participate in dynamic pitch sessions that provide a platform for innovative ideas to thrive, connecting visionaries with potential investors and collaborators.

🐥 Thanks to the Super Early Bird offer, running until end of March, you can benefit from very preferential rates to join the BioFIT 2024 edition.

In 2024, BioFIT will be organised together with MedFIT, dedicated to innovation partnerships and investment rounds in the MedTech and Diagnostic sectors, as well as MEDigIT, the new European convention for Digital Health innovation.

If you’re interested in attending MedFIT and MEDigIT as well, please contact us.

✨ We are more than ready to ensure that 2024 will be rich in opportunities and collaborations.
We look forward to welcoming you to BioFIT in Lille on December 3rd & 4th, and online on December 11th & 12th, 2024.

Sponsors

Contact

Vincent Tavernier

The BioFIT event team wishes you a Happy New Year 2024 Read More »

BioFIT 2023: An overwhelming success!

BioFIT 2023: An overwhelming success!

After 2 lively days in Marseille and a day of engaging digital networking, BioFIT 2023 has come to an end, leaving us with memories of a vibrant event!

The 12th edition of BioFIT, Europe’s leading partnering event for early-stage deals and investment rounds in the Life Sciences field, took place in Marseille, on December 12th and 13th and online, on December 15th.

With 950 international participants, BioFIT 2023 brought together a wide range of key innovation players in Life Sciences, including large biotech companies, start-ups, SMEs, academic and public research institutions, technology transfer offices and seasoned investors. 

Through insightful conferences, valuable networking, and cutting-edge innovations, this edition of BioFIT served to further push the boundaries of healthcare innovation

Stay tuned for more on what came out of BioFIT 2023 and what we have in store for you in 2024.

BioFIT 2023 key numbers

🌐 950 participants from 35 countries
💬 100 exhibitors
🎤 65 international speakers
🚀 56 innovation projects selected to pitch
🤝 3,000 meetings made through the partnering system

BioFIT is back in Lille in 2024

We look forward to welcoming you to the upcoming BioFIT event in the delightful city of Lille, on December 3rd and 4th, 2024.

 In 2024, BioFIT will be organised together with MedFIT, dedicated to innovation partnerships and investment rounds in the MedTech and Diagnostic sectors, as well as MEDigIT, the new European convention for Digital Health innovation.

Register before March 28th, 2024 to
benefit from the Super Early Bird offer

The BioFIT team wishes you Happy Holidays 🎄

Sponsors

Contact

Vincent Tavernier

BioFIT 2023: An overwhelming success! Read More »

Pfizer is a proud sponsor of BioFIT 2023

Pfizer is a proud sponsor of BioFIT 2023

Partners: Let’s team up for Breakthroughs!

Partnerships can save lives. That’s why at Pfizer we’re eager to work with innovators to push forward great science and continually seek new partners that are actively researching bold scientific ideas, capabilities and technologies that have the potential to bring innovative treatments to patients in need. Discover Pfizer’s key areas of interest where we are looking to partner with others, and join the long history of successful partnerships with Pfizer to deliver breakthroughs that change patients’ lives

Pfizer @BioFIT 2023
 
Pfizer is excited to be back at BioFIT to meet new partners at our partnering booth #37. 

Don’t miss Pfizer’s conferences at BioFIT:
  • What are pharma companies’ expectations for pre-competitive research?, panel discussion, on Wednesday, December 13th at 10.30 am with Anette Sommer, Senior Director Emerging Science Lead Oncology Europe, Pfizer
  • Partnering with Pfizer Research & Development, on Wednesday, December 13th at 11.45 am with Sabrina Lesage, Strategic Alliances Senior Manager, Pfizer, & Alain Martelli, Emerging Science Lead, Pfizer Research & Development
About Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us.

Not registered yet for BioFIT?
Register now for a chance to meet the Pfizer team!

Sponsors

Contact

Vincent Tavernier

Pfizer is a proud sponsor of BioFIT 2023 Read More »

🔔 Last call: only 1 week left to register

🔔 Last call: only 1 week left to register

⏳ The countdown has officially begun! BioFIT, Europe’s leading partnering event for early-stage deals and investment rounds bringing together 1,000 international Life Sciences players, is just around the corner. The event kicks off next Tuesday 12th December in Marseille, France, followed by its digital day on December 15th

Don’t wait any longer to register and have the opportunity to meet with key players such as: AbbVie, AdBio partners, Andera Partners, Apollo Health Ventures, Bayer, Astellas, BIOASTER, Biofortis, Boehringer Ingelheim, CAPTECH Santé Nutrition, Charles River Laboratories, CNRS, EQT Life Sciences, EMBLEM Technology Transfer, Fund+, Eurofins, Genfit, GSK Glaxo Smith Kline, High-Tech Gründerfonds, INRAE Transfer, Ipsen, Jeito, Merck, MSD, Novo Holdings, Novo Nordisk, Pfizer, Réseau SATT, Roche, Sofinnova Partners, Spartners by Servier & Biolabs, Sterling Pharma Solutions, Thermo Fischer Scientific, Trinity College Dublin, Virbac, X’PROCHEM, Zoetis… and many more.

Time is running out, get your pass now. Do not hesitate to contact us for any additional information.

Sponsors

Contact

Vincent Tavernier

🔔 Last call: only 1 week left to register Read More »

📖 The AFSSI magazine is now available! 📖

📖 The AFSSI magazine is now available! 📖

But what is it? 🤔
👉 It’s a magazine made to better understand the positioning of AFSSI Sciences de la Vie (L’Association Française des Sociétés de Services et d’Innovation) in the healthcare innovation value chain in France.

AFSSI chairman Hugues Contamin says: “We have a vision, to make France the European leader in preclinical research”.

This 100% AFSSI issue of BIOLIFE aims to show that the pre-clinical phase is a crucial stage in the drug development chain.

96 pages dedicated to R&D partner companies, covering 4 main themes:
1️⃣  The battle for competitiveness in healthcare
2️⃣   The use of animals for scientific purposes: the duty of ethics
3️⃣   Sovereignty and innovation in France
4️⃣   Inventing tomorrow’s technologies

But to what end? 🤔
👉 To reach all the players in the French healthcare ecosystem:
✅public authorities
✅political decision-makers
✅start-ups
✅laboratories
✅ investors in innovation and research institutes

And why? 🤔
👉To demonstrate that the expertise of our companies is part of the solution to societal and environmental problems, in order to reconcile innovation and progress.

Discover in-depth articles, interviews with our members and opinion leaders:

Sponsors

Contact

Vincent Tavernier

📖 The AFSSI magazine is now available! 📖 Read More »

Genfit, Silver Sponsor of BioFIT 2023

Genfit, Silver Sponsor of BioFIT 2023

GENFIT is proud to support the next edition of BioFIT that will take place this year in Marseille, France, on December 12th and 13th, 2023.

About Genfit
 
GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Today, GENFIT has a growing and diversified pipeline with programs at various development stages. The Company’s area of focus is Acute on Chronic Liver Failure (ACLF). Its ACLF franchise consists of five assets in development. Other assets target other life-threatening disease indications such as cholangiocarcinoma (CCA) and Urea Cycle Disorders (UCD)/Organic Acidemias (OA).

For over 2 decades, GENFIT has been focusing its efforts on the discovery and development of drug candidates and diagnostic solutions. Every day, our 100+ employees use their scientific and clinical expertise to improve the lives of patients with rare and life-threatening liver diseases characterized by high unmet medical needs. You can have that impact too! Interested in joining us?
Take a look at our job opportunities or submit your application at jobs.genfit.com

Not registered yet for BioFIT?
Register now for a chance to meet the Genfit team!

Sponsors

Contact

Vincent Tavernier

Genfit, Silver Sponsor of BioFIT 2023 Read More »

Learn more about Boehringer Ingelheim, Silver Sponsor of BioFIT

Learn more about Boehringer Ingelheim, Silver Sponsor of BioFIT

Dear Colleagues and BioFIT delegates,

We’re excited to be back at BioFIT to meet new partners who share our passion for innovation and collaboration.

Our goal is to discover and develop breakthroughs that solve the biggest challenges in human and animal health. That starts with innovation. We’re committed to investing in and advancing emerging science. And we look forward to connecting with the biotechs, academics, TTOs and research institutions attending BioFIT to discover how we can work together to advance innovation and provide solutions to address the many areas of unmet need that remain in human and animal health.

Register on the BioFIT partnering platform to meet us in person or virtually. Our onsite meeting booth is number 67.

You can also hear from our team as they take part in key conference sessions:
Join Hervé Poulet, Director Strategic Partnering, Animal Health for the discussion on: Sourcing innovations from a more mature human health market to build assets and start-ups in animal health, on Tuesday, December 12th, 2.00 – 3.00 pm.
Join Julie Edwards, Director of Alliance Management, for the discussion on: Best practices in managing early-stage academia-industry collaborations, on Wednesday, December 13th, 3.30 – 4.30 pm.
We look forward to meeting you!

About Boehringer Ingelheim

As an independent company active in both human and animal health, Boehringer Ingelheim has learned over generations that the challenging path towards health innovation requires long-term commitment, resilience, and transformative action. Decades of cutting-edge science and innovation has enabled us to deliver pioneering breakthroughs for some of the most devastating diseases in many challenging areas we face globally. Continuing this journey hinges on collaboration.
 
We believe that working together with our global community of partners brings critical diversity to innovation and accelerates the next breakthroughs in human and animal health that will transform lives now and in generations to come. This collective power, in the tireless pursuit of science and solutions, enables us to build together a healthier, more sustainable, and equitable tomorrow.

Not registered yet for BioFIT?
Register now for a chance to meet the Boehringer Ingelheim team!

Sponsors

Contact

Vincent Tavernier

Learn more about Boehringer Ingelheim, Silver Sponsor of BioFIT Read More »

Scroll to Top
  • No products in the cart.